A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Clinical trial NCT01920568 · COMPLETED

Trial details

NCT number: NCT01920568
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fractures, Bone

Start date: 2013-08-01
Primary completion: 2015-02-01
Enrollment: 487

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.